Page last updated: 2024-08-24

fluorodopa f 18 and Degenerative Diseases, Central Nervous System

fluorodopa f 18 has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Broussolle, E; Guillouet, S; Thobois, S1

Reviews

1 review(s) available for fluorodopa f 18 and Degenerative Diseases, Central Nervous System

ArticleYear
Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Neurophysiologie clinique = Clinical neurophysiology, 2001, Volume: 31, Issue:5

    Topics: Aging; Animals; Antiparkinson Agents; Basal Ganglia; Brain Tissue Transplantation; Cell Transplantation; Cerebrovascular Circulation; Diagnosis, Differential; Dihydroxyphenylalanine; Dopamine Agonists; Electric Stimulation Therapy; Fetal Tissue Transplantation; Forecasting; Genetic Predisposition to Disease; Humans; Iatrogenic Disease; Imagination; Ligands; Mesencephalon; Motor Activity; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Radiopharmaceuticals; Rats; Receptors, Dopamine; Risk; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tremor

2001